Brixia International Conference 2016

Aim of the Congress is to present the most updated research results on the treatment of different psychiatric conditions as schizophrenia, major depression, bipolar disorder and anxiety disorders. Moreover, some specific issues relevant to treatment will be addressed.

Among these, will be analyzed:

1. the clinical management of treatment-resistant schizophrenia and treatment-resistant depression;
2. lifestyles and wellness in schizophrenia and mood disorders;
3. the recognition of pathological outcomes of gaming and other addictive behaviors as well as the biological bases and principles of treatment of pathological gambling;
4. the issue of personalized treatment in psychiatry, also from the geneticperspective;
5. the social and economic correlates of suicide in Europe

The congress has been accredited for the following categories:

CHEMIST (hospital pharmacy)
PSYCHOLOGIST (psychotherapy; psychology)
PHYSICIAN (neurology; infant neuropsychiatry; psychiatry; pharmacology & clinic toxicology; general medicine – family doctor)

*the CME credits will be awarded to the participants that will fullfill all the obbligations under the program of Continuing Medical Education

Kapcsolódó dokumentumok (1)

Brixia International Conference 2016		pdf		2016.04.26.		0,145 Mb